150 related articles for article (PubMed ID: 23755872)
21. Stability of visual acuity improvement following discontinuation of amblyopia treatment in children aged 7 to 12 years.
Hertle RW; Scheiman MM; Beck RW; Chandler DL; Bacal DA; Birch E; Chu RH; Holmes JM; Klimek DL; Lee KA; Repka MX; Weakley DR;
Arch Ophthalmol; 2007 May; 125(5):655-9. PubMed ID: 17502505
[TBL] [Abstract][Full Text] [Related]
22. Part time patching treatment outcomes in children with amblyopia with and without fusion maldevelopment nystagmus: An eye movement study.
Scaramuzzi M; Murray J; Otero-Millan J; Nucci P; Shaikh AG; Ghasia FF
PLoS One; 2020; 15(8):e0237346. PubMed ID: 32790721
[TBL] [Abstract][Full Text] [Related]
23. Supervised dichoptic gaming versus monitored occlusion therapy for childhood amblyopia: Effectiveness and efficiency.
Kadhum A; Tan ETC; Fronius M; Baart SJ; Levi DM; Joosse MV; Simonsz HJ; Loudon SE
Acta Ophthalmol; 2024 Feb; 102(1):38-48. PubMed ID: 37078540
[TBL] [Abstract][Full Text] [Related]
24. Feasibility of a clinical trial of vision therapy for treatment of amblyopia.
Lyon DW; Hopkins K; Chu RH; Tamkins SM; Cotter SA; Melia BM; Holmes JM; Repka MX; Wheeler DT; Sala NA; Dumas J; Silbert DI;
Optom Vis Sci; 2013 May; 90(5):475-81. PubMed ID: 23563444
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of Amblyopia Treatments in Children Up to Seven Years Old: A Systematic Review.
Yeritsyan A; Surve AV; Ayinde B; Chokshi P; Adhikari S; Jaimalani A; Hamid P
Cureus; 2024 Mar; 16(3):e56705. PubMed ID: 38650802
[TBL] [Abstract][Full Text] [Related]
26. Subnormal visual acuity after compliant amblyopia therapy: residual/refractory amblyopia or co-existing pathology? - a retrospective analysis.
Sachdeva V; Bhattacharya B; Ganatra S; Kekunnaya R
Strabismus; 2024 Mar; 32(1):11-22. PubMed ID: 38311572
[No Abstract] [Full Text] [Related]
27. Rehabilitation of amblyopia using a digital platform for visual training combined with patching in children: a prospective study.
Hernández-Rodríguez CJ; Ferrer-Soldevila P; Artola-Roig A; Piñero DP
Graefes Arch Clin Exp Ophthalmol; 2024 Apr; ():. PubMed ID: 38578335
[TBL] [Abstract][Full Text] [Related]
28. Randomised controlled trial of treatment of unilateral visual impairment detected at preschool vision screening.
Clarke MP; Wright CM; Hrisos S; Anderson JD; Henderson J; Richardson SR
BMJ; 2003 Nov; 327(7426):1251. PubMed ID: 14644966
[TBL] [Abstract][Full Text] [Related]
29. Comparison of compliance among patients with pediatric amblyopia undergoing virtual reality-based and traditional patching method training.
Li L; Xue H; Lai T; Xue Y; Luo G
Front Public Health; 2022; 10():1037412. PubMed ID: 36311619
[TBL] [Abstract][Full Text] [Related]
30. Levodopa/Carbidopa to Augment the Treatment of Amblyopia: A Report by the American Academy of Ophthalmology.
Morrison DG; Heidary G; Chang MY; Binenbaum G; Cavuoto KM; Galvin J; Trivedi R; Kim SJ; Pineles SL
Ophthalmology; 2023 Nov; 130(11):1221-1227. PubMed ID: 37642618
[TBL] [Abstract][Full Text] [Related]
31. Novel Quantitative Contrast Sensitivity Function Enhances the Prediction of Treatment Outcome and Recurrence in Amblyopia.
Liu J; Huang C; Cotter SA; Chan LYL; Yu Y; Jia Y; Ye Q; Feng L; Yao Y; Jiang R; Xiao C; Xu Z; Zhuang Y; He Y; Zhou Y; Chen X; Yuan J; Wen Y; Yu W; Pang Y; Lu ZL; Thompson B; Li J
Invest Ophthalmol Vis Sci; 2024 May; 65(5):31. PubMed ID: 38771572
[TBL] [Abstract][Full Text] [Related]
32. Effects of virtual reality on the treatment of amblyopia in children: A systematic review and meta-analysis.
Shao W; Niu Y; Wang S; Mao J; Xu H; Wang J; Zhang C; Guo L
J Pediatr Nurs; 2023; 72():106-112. PubMed ID: 37494854
[TBL] [Abstract][Full Text] [Related]
33. Durable recovery from amblyopia with donepezil.
Wu C; Gaier ED; Nihalani BR; Whitecross S; Hensch TK; Hunter DG
Sci Rep; 2023 Jun; 13(1):10161. PubMed ID: 37349338
[TBL] [Abstract][Full Text] [Related]
34. Amblyopia treatment outcomes in patients with neurodevelopmental disorders.
Chinn RN; Wilkinson CL; Staffa SJ; Michalak SM; Shoshany TN; Bishop K; Hunter DG; Gaier ED
J AAPOS; 2023 Oct; 27(5):276.e1-276.e8. PubMed ID: 37739211
[TBL] [Abstract][Full Text] [Related]
35. Amblyopia Treatment Outcomes Re-Audit, Comparing Current Outcomes to Those from the 2011-12 Audit.
Blyth M; Bryant S
Br Ir Orthopt J; 2023; 19(1):127-134. PubMed ID: 38143519
[TBL] [Abstract][Full Text] [Related]
36. Contrast sensitivity following amblyopia treatment in children.
Repka MX; Kraker RT; Beck RW; Cotter SA; Holmes JM; Arnold RW; Astle WF; Sala NA; Tien DR;
Arch Ophthalmol; 2009 Sep; 127(9):1225-7. PubMed ID: 19752439
[No Abstract] [Full Text] [Related]
37. New advances in amblyopia therapy: early patching is more effective than extended optical treatment.
Zhou S; Zhou J
Lancet; 2024 May; 403(10438):1725-1727. PubMed ID: 38704157
[No Abstract] [Full Text] [Related]
38. The Amblyopia Treatment Studies: Implications for Clinical Practice.
Chen AM; Cotter SA
Adv Ophthalmol Optom; 2016 Aug; 1(1):287-305. PubMed ID: 28435934
[No Abstract] [Full Text] [Related]
39. Atropine vs patching for treatment of moderate amblyopia: follow-up at 15 years of age of a randomized clinical trial.
Repka MX; Kraker RT; Holmes JM; Summers AI; Glaser SR; Barnhardt CN; Tien DR;
JAMA Ophthalmol; 2014 Jul; 132(7):799-805. PubMed ID: 24789375
[TBL] [Abstract][Full Text] [Related]
40. A randomized trial of adding a plano lens to atropine for amblyopia.
; Wallace DK; Lazar EL; Repka MX; Holmes JM; Kraker RT; Hoover DL; Weise KK; Waters AL; Rice ML; Peters RJ
J AAPOS; 2015 Feb; 19(1):42-8. PubMed ID: 25727586
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
